NCT05386030 - Saypha® VOLUME Lidocaine for Midface Augmentation | Biotech Hunter

Enrollment

562

Participants

Timeline

Start Date

August 16, 2022

Primary Completion Date

October 4, 2023

Study Completion Date

December 11, 2024

Conditions

Moderate to Severe Midface Volume Deficit

Interventions

COMBINATION_PRODUCT

saypha® VOLUME Lidocaine

Crosslinked hyaluronic acid (HA) 23 mg/mL + 0.3% lidocaine hydrochloride.

COMBINATION_PRODUCT

Juvéderm® Voluma™ XC

Crosslinked HA 20 mg/mL + 0.3% lidocaine hydrochloride

Trial Locations (16)

10021

Luxurgery, New York

11790

DermResearchCenter of NY, Stony Brook

27517

Aesthetic Solutions, Chapel Hill

31406

Meridian Clinical Research, Georgia Plastic Surgery, Savannah

33146

Skin Associates of South Florida, Coral Gables

33180

Center for Clinical and Cosmetic Research, Aventura

37215

Tennessee Clinical Research Center, Nashville

60654

Chicago Cosmetic, Chicago

68144

Skin Specialists, Omaha

78759

DermResearch Inc. Austin, Austin

80111

About Skin, Greenwood Village

85255

Clear Dermatology & Aesthetics Center, Scottsdale

91436

Clinical Testing of Beverly Hills, Encino

92121

Cosmetic Laser Dermatology, San Diego

94538

Center for Dermatology Cosmetic & Laser Surgery, Fremont

07042

Imagedermatology PC, Montclair